About the Company
ocuphire is a new biopharmaceuticals company focused on developing and commercializing small molecule drugs for unmet medical needs in the ocular disease space. ocuphire’s lead drug candidate, nyxol eye drops, is aimed to treat patients with night vision disturbances (nvd), glaucoma and presbyopia (impaired near-term vision). ocuphire is in discussions with a prospective late stage ophthalmic drug program that could be developed in parallel. ocuphire's management team has over 100 years of drug development expertise across a diverse set of therapeutic areas including ophthalmology, orphan, cardio-metabolic, nephrology, oncology and respiratory.
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $OCUP News
Earnings Update: Ocuphire Pharma, Inc. (NASDAQ:OCUP) Just Reported And Analysts Are Trimming Their Forecasts
Ocuphire Pharma, Inc. ( NASDAQ:OCUP ) just released its latest yearly report and things are not looking great. It ...
Design Therapeutics And 2 Other Stocks Under $5 Insiders Are Buying
The Dow Jones index closed lower by over 150 points on Monday. When insiders purchase or sell shares, it indicates their ...
Compare with SCHOTT Pharma AG & Co KgaA (STTPF)
Select "Add to Compare" to begin comparing Stocks, ETFs, Mutual Funds and more.
Why Ebonyi is choice destination for Pharma Park project – Pharmacists
Nigerian Association of Industrial Pharmacists has said its choice of Ebonyi State for the establishment of Salt City Pharma Park was hinged on the availability of needed infrastructure and the ...
Loading the latest forecasts...